Join NBTS’s campaign to raise awareness about the importance of biomarker testing and clinical trials for patients with brain tumors.
READ MORENearly 20,000 volunteer advocates across all 50 states affect change at the local, state, and national levels annually. Stay atop the latest action alerts below or by becoming an advocate. With thousands beside us, our collective voices and actions are a powerful force for progress.
The bipartisan BRAIN Act (H.R.2767, S.1330) is the first legislation designed to address the unique challenges faced by brain tumor researchers, clinicians, patients, and survivors. By advancing research, improving treatment access through public awareness of clinical trials and biomarker testing, and enhancing survivorship care, this bill aims to drive critical progress in the fight against brain tumors. Urge your members of Congress to support the BRAIN Act and help secure better treatments, improved quality of life, and a path toward a cure.
The National Institutes of Health (NIH), and its National Cancer Institute (NCI), are the largest funders of brain tumor research in the world. Additionally, the NIH/NCI Clinical Center provides important access to second opinions and clinical trials for patients with brain tumors. Together, these agencies serve as the backbone for scientific and medical innovation in the brain tumor field, funding discovery research that serves as the foundation for breakthroughs in therapeutic strategies as well as supporting clinical research that helps develop, evaluate, and provide access to cutting-edge treatments.
Update from the Capital: Funding for the Congressionally-Directed Medical Research Program Beginning in September of 2024, Congress passed a series of what’s known as “Continuing Resolutions” in lieu of a full set of spending bills – or budget – to fund the government for Fiscal Year 2025. A Continuing Resolution (or “CR”) typically keeps funding for every government function at the same level as the previous […] April 2, 2025
Update from the Capital: Fiscal Year 2025 Funding Update The following is a brief, high-level update on the complicated and very fluid political situation unfolding around a possible government shutdown – and implications for federal funding of brain tumor research. Unless Congress acts, government funding will run out on Friday (March 14). The President recently called for Congress to pass a “Continuing Resolution (CR),” […] March 11, 2025
Update from the Capital: Proposed NIH Policy At the end of January, we shared an update regarding a series of announcements from the new Administration and their potential implications for the brain tumor community. NBTS’s primary concern continues to be whether any of these actions would limit the ability of the National Institutes of Health (NIH) and other federal agencies to provide […] February 14, 2025
Update from the Capital: Government Developments NBTS is currently working to better understand the impact of any of the recent actions and directives announced by the new Administration as it relates to brain tumor research and care at the National Institutes of Health (NIH) and other related federal agencies. This is a developing situation, and new updates are being reported daily […] January 29, 2025